batirtze-areitio Batirtze Areitio Batirtze has over 5 years of experience in the biopharma and biotech industries. She joined ApexOnco in 2025 after working as an analyst at OncologyPipeline. She is a graduate of the University of Navarra, where she earned a degree in biochemistry. Pluvicto miss puts pressure on PSMAfore expansion 23 April 2024 Carvykti joins Abecma in EU expansion 22 April 2024 Alecensa gets its first-mover adjuvant label 19 April 2024 Imfinzi holds its own in bile duct cancer 16 April 2024 Tecvayli threatens to eclipse Carvykti 16 April 2024 Regeneron’s double-whammy, courtesy of Roche 15 April 2024 Bristol’s son of Revlimid goes pivotal 12 April 2024 AACR 2024 – indolent lymphoma presents fresh CD47 promise 11 April 2024 Load More